InvestorsHub Logo
Followers 2
Posts 44
Boards Moderated 0
Alias Born 07/25/2018

Re: None

Thursday, 03/21/2019 8:24:53 AM

Thursday, March 21, 2019 8:24:53 AM

Post# of 474314
“Muscarinic M1 Agonist” | Pipeline Insight Research Report, 2019

https://rochesterleader.com/muscarinic-m1-agonist-pipeline-insight-research-report-2019/

Key-players analyzed in Muscarinic M1 Agonist Pipeline Insight Report: Heptares Therapeutics, WinSanTor, Anavex Life Sciences, Mithridion, Boehringer Ingelheim, Glenmark Pharmaceuticals Ltd, & list continues,
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News